NEWS

Next in line: 35-39 age group able to sign up for vaccination as of Wednesday

Next in line: 35-39 age group able to sign up for vaccination as of Wednesday

The 35-39 age group will be able to set appointments for coronavirus vaccinations as of Wednesday, Health Secretary General Marios Themistocleous said on Monday, and all four vaccines will be available to them.

As Greece has opened most adult age groups for appointments and more vaccines are getting delivered, all types of vaccines - AstraZeneca, Johnson & Johnson, Moderna and Pfizer - used in Greece for age-specific groups are becoming gradually available for all age groups.

The 40–44 age group was the first to be administered all types of vaccines on May 21. Themistocleous added at the regular pandemic briefing that the next group to be added will be the 30-34 one.

He added that on Monday Greece passed the 5-million threshold of inoculations. A total of 3,250,000 individuals have received at least one dose of a vaccine (31 pct of population), and 1,800,000 citizens (17.2 pct) have completed their vaccination with either a two-dose or a single-dose vaccine.

Also speaking at the briefing, head of the National Vaccination Committee Maria Theodoridou said the committee recommends that people who have recovered from Covid-19 be vaccinated between 6 and 12 months after the illness' onset.

The medical expert explained that the decision is based on a revision of understanding of immunity achieved through antibodies, whose life span can reach up to 12 months or beyond.

Citing another study, she highlighted the fact that both the Pfizer and AstraZeneca vaccines are effective against the British and Indian coronavirus variants, at 86 pct and 66 pct respectively.

Vaccines are also safe for pregnant women or those nursing their babies, Theodoridou underlined. She also pointed out that it was wrong for people who have had side effects after the first vaccination to cancel their appointments for the second one, as the side effects are expected for vaccinations.

Source: ana-mpa